Stephen J Hoffman - Net Worth and Insider Trading
Stephen J Hoffman Net Worth
The estimated net worth of Stephen J Hoffman is at least $4,713 dollars as of 2024-04-26. Stephen J Hoffman is the CEO of Aerpio Pharmaceuticals Inc and owns about 2,131 shares of Aerpio Pharmaceuticals Inc (ARPO) stock worth over $4,688. Stephen J Hoffman is also the Director of Genocea Biosciences Inc and owns about 249,052 shares of Genocea Biosciences Inc (GNCAQ) stock worth over $25. Details can be seen in Stephen J Hoffman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Stephen J Hoffman has not made any transactions after 2018-11-12 and currently still holds the listed stock(s).
Transaction Summary of Stephen J Hoffman
Stephen J Hoffman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephen J Hoffman owns 8 companies in total, including Talphera Inc (TLPH) , Dicerna Pharmaceuticals Inc (DRNA) , and Aerpio Pharmaceuticals Inc (ARPO) among others .
Click here to see the complete history of Stephen J Hoffman’s form 4 insider trades.
Insider Ownership Summary of Stephen J Hoffman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TLPH | Talphera Inc | 2012-05-29 | director & 10 percent owner |
| DRNA | Dicerna Pharmaceuticals Inc | 2020-06-15 | director |
| ARPO | Aerpio Pharmaceuticals Inc | 2019-05-14 | director & Chief Executive Officer |
| GNCAQ | Genocea Biosciences Inc | 2015-03-17 | director |
| TTPH | Tetraphase Pharmaceuticals Inc | 2014-03-12 | 10 percent owner |
| AADI | Aadi Bioscience Inc | 2017-12-01 | Chief Executive Officer |
| RACB | Research Alliance Corp II | 2021-03-17 | director |
| GGNNQ | Genocea Biosciences Inc | 2015-02-26 | director |
Stephen J Hoffman Latest Holdings Summary
Stephen J Hoffman currently owns a total of 2 stocks. Among these stocks, Stephen J Hoffman owns 2,131 shares of Aerpio Pharmaceuticals Inc (ARPO) as of November 12, 2018, with a value of $4,688 and a weighting of 99.47%. Stephen J Hoffman also owns 249,052 shares of Genocea Biosciences Inc (GNCAQ) as of March 17, 2015, with a value of $25 and a weighting of 0.53%.
Latest Holdings of Stephen J Hoffman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARPO | Aerpio Pharmaceuticals Inc | 2018-11-12 | 2,131 | 2.20 | 4,688 |
| GNCAQ | Genocea Biosciences Inc | 2015-03-17 | 249,052 | 0.00 | 25 |
Holding Weightings of Stephen J Hoffman
Stephen J Hoffman Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephen J Hoffman has made a total of 0 transactions in Aerpio Pharmaceuticals Inc (ARPO) over the past 5 years. The most-recent trade in Aerpio Pharmaceuticals Inc is the acquisition of 2,131 shares on November 12, 2018, which cost Stephen J Hoffman around $64,254.
According to the SEC Form 4 filings, Stephen J Hoffman has made a total of 0 transactions in Genocea Biosciences Inc (GNCAQ) over the past 5 years. The most-recent trade in Genocea Biosciences Inc is the acquisition of 87,500 shares on March 17, 2015, which cost Stephen J Hoffman around $6 Million.
Insider Trading History of Stephen J Hoffman
- 1
Stephen J Hoffman Trading Performance
GuruFocus tracks the stock performance after each of Stephen J Hoffman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephen J Hoffman is 56.56%. GuruFocus also compares Stephen J Hoffman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephen J Hoffman within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stephen J Hoffman's insider trading performs compared to the benchmark.
Performance of Stephen J Hoffman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 19.49 | 56.56 | -22.74 | -63.8 | -18.95 | -50.83 |
| Relative Return to S&P 500(%) | 20.71 | 55.59 | -23.56 | -69.69 | -29.42 | -60.71 |
Stephen J Hoffman Ownership Network
Ownership Network List of Stephen J Hoffman
Ownership Network Relation of Stephen J Hoffman
Stephen J Hoffman Owned Company Details
What does Talphera Inc do?
Who are the key executives at Talphera Inc?
Stephen J Hoffman is the director & 10 percent owner of Talphera Inc. Other key executives at Talphera Inc include director & Chief Executive Officer Vincent J. Angotti , director & Chief Medical Officer Pamela P Palmer , and Chief Engineering Officer Badri N Dasu .
Talphera Inc (TLPH) Insider Trades Summary
Over the past 18 months, Stephen J Hoffman made no insider transaction in Talphera Inc (TLPH). Other recent insider transactions involving Talphera Inc (TLPH) include a net purchase of 20,000 shares made by Vincent J. Angotti , and a net sale of 16,956 shares made by Pamela P Palmer .
In summary, during the past 3 months, insiders sold 0 shares of Talphera Inc (TLPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 16,956 shares of Talphera Inc (TLPH) were sold and 20,000 shares were bought by its insiders, resulting in a net purchase of 3,044 shares.
Talphera Inc (TLPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Talphera Inc Insider Transactions
Stephen J Hoffman Mailing Address
Above is the net worth, insider trading, and ownership report for Stephen J Hoffman. You might contact Stephen J Hoffman via mailing address: C/o Skyline Ventures, 525 University Ave., Suite 1350, Palo Alto Ca 94301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
